• Explore /
  • Poster
  • / Randomised phase III study of gemcitabine, cisplatin plus S-1 (GCS) compared with gemcitabine plus cisplatin (GC) for unresectable or recurrent biliary tract cancer (KHBO1401-MITSUBA).

Randomised phase III study of gemcitabine, cisplatin plus S-1 (GCS) compared with gemcitabine plus cisplatin (GC) for unresectable or recurrent biliary tract cancer (KHBO1401-MITSUBA).

Abstract Poster

Authors

null

Tatsuya Ioka

Hepatobiliary and Pancreatic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

Tatsuya Ioka , Masashi Kanai , Shogo Kobayashi , Daisuke Sakai , Amane Kitasato , Hiroki Yamaue , Hideyuki Hayashi , Naoko Chayahara , Masahiro Takahashi , Takatsugu Yamada , Etsuro Hatano , Takuma Goto , Jiro Fujimoto , Masahiro Murakami , Keiko Kamei , Kenichi Yoshimura

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT02182778

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS4141)

DOI

10.1200/jco.2015.33.15_suppl.tps4141

Abstract #

TPS4141

Poster Bd #

248a

Abstract Disclosures

Similar Posters

First Author: Noriko Fujishiro

First Author: Chigusa Morizane

First Author: Satoshi Nara

First Author: Tatsuya Okuno